1. Health
Send to a Friend via Email

CA-125 Test for Ovarian Cancer

Facts About the CA-125 Test

By

Updated September 17, 2009

The CA-125 test is a screening tool that measures the amount of a protein (CA-125) in the blood. Elevated levels can indicate ovarian cancer in some women and also recurrence in women who have previously been diagnosed and treated for the disease.

What is CA-125

CA-125 (cancer antigen-125) is a protein found at elevated concentrations in ovarian cancer cells that is released into the bloodstream. A simple blood test can measure CA-125 levels in the blood. This test is also called a CA-125 tumor marker or biomarker test.

Why the CA-125 Test is Not Used as a Screening Tool for All Women Yet

One of the major flaws in the use of the CA-125 to screen for ovarian cancer in average risk women is that an elevated CA-125 level doesn't always equal ovarian cancer. Elevated CA-125 levels can be caused by a myriad of conditions, such as endometriosis, diverticulitis, cirrhosis, uterine fibroids, pregnancy, and even menstruation. Certain cancer treatment drugs can also influence the test, producing a false positive.

Not all women who have ovarian cancer have elevated CA-125 levels, so a normal level does not mean that a woman does not have ovarian cancer. The test simply fails to detect 100 percent of true cases of ovarian cancer and misdiagnoses the disease because of the presence of common conditions, like the ones listed above.

The door is not closed on the possibility of a CA-125 screening test for ovarian cancer. Several studies are underway to determine how the test could be used to screen at average risk women, much like a Pap smear. [h2]Who Should Get the CA-125 Test Women who are at a high risk of developing ovarian cancer may benefit from regular CA-125 screening. If you have a strong family risk of ovarian or breast cancer, it may be recommended that you have regular screenings. Some doctors may want to do a genetic test to see if you have a mutated BRCA1 or BRCA2 gene before making a recommendation about screening. When these genes are mutated, it can greatly increase the risk of ovarian cancer in women.

Some women who have been previously diagnosed and successfully treated opt to have regular CA-125 screenings. The effectiveness at detecting ovarian cancer early is still debated among some physicians, so not every doctor supports the test. If you were previously treated for ovarian cancer and would like to be screened, talk to your doctor. You also have the choice to decline having regular CA-125 screenings, as well. Some women feel that regular screening cause too much stress and worry that interferes with their everyday lives. The decision to be have regular screenings is personal and should be discussed with your doctor.

If you are currently being treated for ovarian cancer, your doctor may want to order regular CA-125 tests to gauge the protein levels throughout treatment. CA-125 levels can measure how well you are responding to treatment. Decreasing levels can indicate that treatment is effective. Prior to beginning treatment, your doctor may order a baseline CA-125, which he will use to compare future CA-125 test results.

Source:

Berek, Johanthan S. "Practical Gynecological Oncology." Lippincott Williams & Wilkins, 2004

  1. About.com
  2. Health
  3. Cancer
  4. Women's Cancers
  5. Ovarian Cancer
  6. CA-125 - Facts About the CA-125 Test for Ovarian Cancer

©2014 About.com. All rights reserved.

We comply with the HONcode standard
for trustworthy health
information: verify here.